Adirondack Trust CO Adma Biologics, Inc. Transaction History
Adirondack Trust CO
- $259 Million
- Q3 2024
A detailed history of Adirondack Trust CO transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Adirondack Trust CO holds 585 shares of ADMA stock, worth $11,430. This represents 0.0% of its overall portfolio holdings.
Number of Shares
585
Previous 585
-0.0%
Holding current value
$11,430
Previous $6,000
83.33%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ADMA
# of Institutions
319Shares Held
185MCall Options Held
917KPut Options Held
91.6K-
Black Rock Inc. New York, NY18.6MShares$364 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$354 Million0.01% of portfolio
-
State Street Corp Boston, MA13MShares$254 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.6MShares$247 Million0.05% of portfolio
-
Morgan Stanley New York, NY8.6MShares$168 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.84B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...